Ohio State University Developed Drug Receives FDA Approval for Treatment of CLL and SLL

Ohio State University Developed Drug Receives FDA Approval for Treatment of CLL and SLL

A drug developed at Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) in collaboration with biopharma venture partner Acerta Pharma benefited from FDA approval as a first-line...
Investigator Profile: Dr. Jennifer Woyach, Nationally-Recognized Expert on Chronic Lymphocytic Leukemia (CLL) Clinical Trials

Investigator Profile: Dr. Jennifer Woyach, Nationally-Recognized Expert on Chronic Lymphocytic Leukemia (CLL) Clinical Trials

OncLive interviews Jennifer A. Woyach, MD, on the current research and treatment spectrum for chronic lymphocytic leukemia (CLL). Dr. Woyach, an investigator with The James Ohio State University Comprehensive Cancer Center, is a nationally recognized CLL expert and...

Pin It on Pinterest